ipriflavone has been researched along with Osteomalacia in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Osteomalacia: Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, M | 1 |
| Suzuki, K | 1 |
| Hidaka, T | 1 |
| Shinohara, T | 1 |
| Kataharada, K | 1 |
| Matsumoto, M | 1 |
| Takada, K | 1 |
| Ohsuzu, F | 1 |
1 other study available for ipriflavone and Osteomalacia
| Article | Year |
|---|---|
Rapid improvement of osteomalacia by treatment in a case with Sjögren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1.
Topics: Acidosis, Renal Tubular; Adjuvants, Immunologic; Analgesics; Arthritis, Rheumatoid; Bone Density; Ca | 2001 |